32. Winters AA, Bou-Ghannam S, Thorp H, et al. Evaluation of multiple
biological therapies for ischemic cardiac disease. Cell Transplant. 2016; 25(9):
1591-1607.
33. Wang J, Zhang S, Rabinovich B, et al. Human CD34+ cells in
experimental myocardial infarction: long-term survival, sustained functional
improvement, and mechanism of action. Circ Res. 2010;106(12):1904-11.oi:
10.1161/CIRCRESAHA.110.221762.
34. Zhang S, Shpall E, Willerson JT, Yeh ET. Fusion of human
hematopoietic progenitor cells and murine cardiomyocytes is mediated by alpha 4
beta 1 integrin/vascular cell adhesion molecule-1 interaction. Circ Res. 2007;
100(5): 693-702.
35. Shabbir A, Zisa D, Suzuki G, Lee T. Heart failure therapy mediated by
the trophic activities of bone marrow mesenchymal stem cells: a noninvasive
therapeutic regimen. Am J Physiol Heart Circ Physiol. 2009; 296(6): H1888-97.
doi: 10.1152/ajpheart.00186.2009
Chương 9
1. Fried LP, Tangen CM, Watson J, et al. Cardiovascular Health Study
Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J
Gerontol A Biol Sci Med Sci. 2001; 56(3): M146-56.
2. Lally F, Crome P. Understanding frailty. Postgrad Med J. 2007; 83(975):
16-20. doi: 10.1136/pgmj.2006.048587.
3. Espinoza S, Walston JD. Frailty in older adults: insights and interventions.
Cleve Clin J Med. 2005; 72(12): 1105-12.
4. Marcell TJ. Sarcopenia: causes, consequences, and preventions. J
Gerontol A Biol Sci Med Sci. 2003; 58(10): M911-M916.
5. Jensen GL. Inflammation: roles in aging and sarcopenia. JPEN J Parenter
Enteral Nutr. 2008; 32(6): 656-9.
6. de Gonzalo-Calvo D, Neitzert K, Fernández M, et al. Differential
inflammatory responses in aging and disease: TNF-alpha and IL-6 as possible
